Investigating how tissue stiffness and genetic factors affect age-related macular degeneration
Role of Matrix Stiffness and Genetic Risk Factors in AMD-Associated Epithelial-to-Mesenchymal Transition
This study is looking at how the stiffness of eye tissue and certain genetic factors might contribute to age-related macular degeneration (AMD), with the hope of finding new ways to treat this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11144509 on NIH RePORTER |
What this research studies
This research explores the relationship between tissue stiffness and genetic risk factors in the development of age-related macular degeneration (AMD). It aims to understand how changes in the extracellular matrix (ECM) stiffness can lead to a process called epithelial-to-mesenchymal transition (EMT) in retinal cells. By using laboratory models, the study will examine how these mechanical changes influence the behavior of retinal pigmented epithelial and choroidal endothelial cells, which are crucial in AMD progression. The findings could pave the way for new treatments targeting the underlying mechanisms of AMD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for age-related macular degeneration, particularly those with genetic predispositions or lifestyle factors that contribute to the disease.
Not a fit: Patients with advanced stages of age-related macular degeneration or those without any genetic risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that slow down or prevent the progression of age-related macular degeneration.
How similar studies have performed: Previous research has shown promising results in understanding the role of ECM stiffness in other tissues, suggesting that this approach may yield valuable insights for AMD as well.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Worthington, Kristan Sorenson — University of Iowa
- Study coordinator: Worthington, Kristan Sorenson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.